Cargando…

Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial

Background: Probiotic supplementation to women during pregnancy and lactation can modulate breast milk composition, with immune benefits being transferred to their infants. Aim: The aim of the study was to evaluate the effect of high-dose probiotic supplementation to women during late pregnancy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldassarre, Maria Elisabetta, Di Mauro, Antonio, Mastromarino, Paola, Fanelli, Margherita, Martinelli, Domenico, Urbano, Flavia, Capobianco, Daniela, Laforgia, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133065/
https://www.ncbi.nlm.nih.gov/pubmed/27801789
http://dx.doi.org/10.3390/nu8110677
_version_ 1782471201589821440
author Baldassarre, Maria Elisabetta
Di Mauro, Antonio
Mastromarino, Paola
Fanelli, Margherita
Martinelli, Domenico
Urbano, Flavia
Capobianco, Daniela
Laforgia, Nicola
author_facet Baldassarre, Maria Elisabetta
Di Mauro, Antonio
Mastromarino, Paola
Fanelli, Margherita
Martinelli, Domenico
Urbano, Flavia
Capobianco, Daniela
Laforgia, Nicola
author_sort Baldassarre, Maria Elisabetta
collection PubMed
description Background: Probiotic supplementation to women during pregnancy and lactation can modulate breast milk composition, with immune benefits being transferred to their infants. Aim: The aim of the study was to evaluate the effect of high-dose probiotic supplementation to women during late pregnancy and lactation on cytokine profile and secretory IgA (sIgA) in breast milk and thus to study if differences in breast milk composition can affect lactoferrin and sIgA levels in stool samples of newborns. The safety of maternal probiotic administration on neonatal growth pattern and gastrointestinal symptoms were also evaluated. Methods: In a double-blind, placebo-controlled, randomized trial, 66 women took either the probiotic (n = 33) or a placebo (n = 33) daily. Levels of interleukins (IL-6, IL-10 and IL-1β), transforming growth factor-β1 (TGF-β1), and sIgA in breast milk; and the level of sIgA and lactoferrin in newborn stool samples were analyzed at birth and then again at one month of life. Antropometrical evaluation and analysis of gastrointestinal events in newborns was also performed. Results: Probiotic maternal consumption had a significant impact on IL6 mean values in colostrum and on IL10 and TGF-β1 mean values in mature breast milk. Fecal sIgA mean values were higher in newborns whose mothers took the probiotic product than in the control group. Probiotic maternal supplementation seems to decrease incidence of infantile colic and regurgitation in infants. Conclusion: High-dose multi-strain probiotic administration to women during pregnancy influences breast milk cytokines pattern and sIgA production in newborns, and seems to improve gastrointestinal functional symptoms in infants.
format Online
Article
Text
id pubmed-5133065
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-51330652016-12-11 Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial Baldassarre, Maria Elisabetta Di Mauro, Antonio Mastromarino, Paola Fanelli, Margherita Martinelli, Domenico Urbano, Flavia Capobianco, Daniela Laforgia, Nicola Nutrients Article Background: Probiotic supplementation to women during pregnancy and lactation can modulate breast milk composition, with immune benefits being transferred to their infants. Aim: The aim of the study was to evaluate the effect of high-dose probiotic supplementation to women during late pregnancy and lactation on cytokine profile and secretory IgA (sIgA) in breast milk and thus to study if differences in breast milk composition can affect lactoferrin and sIgA levels in stool samples of newborns. The safety of maternal probiotic administration on neonatal growth pattern and gastrointestinal symptoms were also evaluated. Methods: In a double-blind, placebo-controlled, randomized trial, 66 women took either the probiotic (n = 33) or a placebo (n = 33) daily. Levels of interleukins (IL-6, IL-10 and IL-1β), transforming growth factor-β1 (TGF-β1), and sIgA in breast milk; and the level of sIgA and lactoferrin in newborn stool samples were analyzed at birth and then again at one month of life. Antropometrical evaluation and analysis of gastrointestinal events in newborns was also performed. Results: Probiotic maternal consumption had a significant impact on IL6 mean values in colostrum and on IL10 and TGF-β1 mean values in mature breast milk. Fecal sIgA mean values were higher in newborns whose mothers took the probiotic product than in the control group. Probiotic maternal supplementation seems to decrease incidence of infantile colic and regurgitation in infants. Conclusion: High-dose multi-strain probiotic administration to women during pregnancy influences breast milk cytokines pattern and sIgA production in newborns, and seems to improve gastrointestinal functional symptoms in infants. MDPI 2016-10-27 /pmc/articles/PMC5133065/ /pubmed/27801789 http://dx.doi.org/10.3390/nu8110677 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Baldassarre, Maria Elisabetta
Di Mauro, Antonio
Mastromarino, Paola
Fanelli, Margherita
Martinelli, Domenico
Urbano, Flavia
Capobianco, Daniela
Laforgia, Nicola
Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial
title Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial
title_full Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial
title_fullStr Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial
title_full_unstemmed Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial
title_short Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial
title_sort administration of a multi-strain probiotic product to women in the perinatal period differentially affects the breast milk cytokine profile and may have beneficial effects on neonatal gastrointestinal functional symptoms. a randomized clinical trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133065/
https://www.ncbi.nlm.nih.gov/pubmed/27801789
http://dx.doi.org/10.3390/nu8110677
work_keys_str_mv AT baldassarremariaelisabetta administrationofamultistrainprobioticproducttowomenintheperinatalperioddifferentiallyaffectsthebreastmilkcytokineprofileandmayhavebeneficialeffectsonneonatalgastrointestinalfunctionalsymptomsarandomizedclinicaltrial
AT dimauroantonio administrationofamultistrainprobioticproducttowomenintheperinatalperioddifferentiallyaffectsthebreastmilkcytokineprofileandmayhavebeneficialeffectsonneonatalgastrointestinalfunctionalsymptomsarandomizedclinicaltrial
AT mastromarinopaola administrationofamultistrainprobioticproducttowomenintheperinatalperioddifferentiallyaffectsthebreastmilkcytokineprofileandmayhavebeneficialeffectsonneonatalgastrointestinalfunctionalsymptomsarandomizedclinicaltrial
AT fanellimargherita administrationofamultistrainprobioticproducttowomenintheperinatalperioddifferentiallyaffectsthebreastmilkcytokineprofileandmayhavebeneficialeffectsonneonatalgastrointestinalfunctionalsymptomsarandomizedclinicaltrial
AT martinellidomenico administrationofamultistrainprobioticproducttowomenintheperinatalperioddifferentiallyaffectsthebreastmilkcytokineprofileandmayhavebeneficialeffectsonneonatalgastrointestinalfunctionalsymptomsarandomizedclinicaltrial
AT urbanoflavia administrationofamultistrainprobioticproducttowomenintheperinatalperioddifferentiallyaffectsthebreastmilkcytokineprofileandmayhavebeneficialeffectsonneonatalgastrointestinalfunctionalsymptomsarandomizedclinicaltrial
AT capobiancodaniela administrationofamultistrainprobioticproducttowomenintheperinatalperioddifferentiallyaffectsthebreastmilkcytokineprofileandmayhavebeneficialeffectsonneonatalgastrointestinalfunctionalsymptomsarandomizedclinicaltrial
AT laforgianicola administrationofamultistrainprobioticproducttowomenintheperinatalperioddifferentiallyaffectsthebreastmilkcytokineprofileandmayhavebeneficialeffectsonneonatalgastrointestinalfunctionalsymptomsarandomizedclinicaltrial